Renal Angiomyolipoma

Hakan Aydın(Cleveland Clinic), Ming Zhou(Indiana University School of Medicine), Cristina Magi‐Galluzzi(University of Alabama at Birmingham), Brian R. Lane(Grand Rapids Community College), Linda Sercia(Cleveland Clinic), José I. López(BioCruces Health research Institute), Brian I. Rini(Vanderbilt University Medical Center)
The American Journal of Surgical Pathology
January 21, 2009
10.1097/pas.0b013e31817ed7a6
Cited by 253

Related Papers

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
|Journal of Clinical Oncology|2008|907
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
|Cell|2018|883
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
|Cell|2018|680
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
|Cell|2018|565